Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?

Por ZETTINIG, G, TANEW, A, FISCHER, G, MAYR, W, DUDCZAK, R, WEISSEL, M
Publicado em 2003

Improved Quality of Life in Patients Treated with Peptide Radionuclides

Por Traub-Weidinger, T, Raderer, M., Uffmann, M., Angelberger, P., Kurtaran, A., Leimer, M., Preitfellner, J., Dudczak, R., Virgolini, I.
Publicado em 2011

Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation

Por Brunner, M, Ziegler, S, Di Stefano, A F D, Dehghanyar, P, Kletter, K, Tschurlovits, M, Villa, R, Bozzella, R, Celasco, G, Moro, L, Rusca, A, Dudczak, R, Müller, M
Publicado em 2006